Mutations of the Uromodulin Gene in MCKD Type 2 Patients Cluster in Exon 4, Which Encodes Three EGF-Like Domains

Total Page:16

File Type:pdf, Size:1020Kb

Mutations of the Uromodulin Gene in MCKD Type 2 Patients Cluster in Exon 4, Which Encodes Three EGF-Like Domains Kidney International, Vol. 64 (2003), pp. 1580–1587 Mutations of the Uromodulin gene in MCKD type 2 patients cluster in exon 4, which encodes three EGF-like domains MATTHIAS T.F. WOLF,BETTINA E. MUCHA,MASSIMO ATTANASIO,ISABELLA ZALEWSKI, STEPHANIE M. KARLE,HARTMUT P.H. NEUMANN,NAZNEEN RAHMAN,BIRGIT BADER, CONRAD A. BALDAMUS,EDGAR OTTO,RALPH WITZGALL,ARNO FUCHSHUBER, and FRIEDHELM HILDEBRANDT Department of Pediatrics and Communicable Diseases, University of Michigan, Ann Arbor, Michigan; University Children’s Hospital, Freiburg University, Freiburg, Germany; Department of Internal Medicine, University Hospital, Freiburg University, Freiburg, Germany; Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom; Department of Internal Medicine, University Hospital, Tuebingen University, Tuebingen, Germany; Department of Internal Medicine, University Hospital, Cologne University, Cologne, Germany; and Institute for Molecular and Cellular Anatomy, University of Regensburg, Regensburg, Germany Mutations of the Uromodulin gene in MCKD type 2 patients Medullary cystic kidney disease type 2 (MCKD2) cluster in exon 4, which encodes three EGF-like domains. (OMIM 603860) includes clinical features of reduced Background. Autosomal-dominant medullary cystic kidney urinary concentration, salt wasting, and end-stage renal disease type 2 (MCKD2) is a tubulointerstitial nephropathy that causes renal salt wasting, hyperuricemia, gout, and end-stage re- failure. In contrast to MCKD1, in MCKD2, a more se- nal failure in the fifth decade of life. The chromosomal locus for vere phenotype concerning hyperuricemia and gout has MCKD2 was localized on chromosome 16p12. Within this chro- been described. Moreover, in MCKD2, an earlier median mosomal region, Uromodulin (UMOD) was located as a candi- age of onset has been reported (age of onset in MCKD2 date gene. UMOD encodes the Tamm-Horsfall protein. By se- is 32 years of age compared to 62 years in MCKD1) [1]. quence analysis, one group formerly excluded UMOD as the disease-causing gene. In contrast, recently, another group de- Otherwise, these two diseases are clinically undistinguish- scribed mutations in the UMOD gene as responsible for MCKD2 able. In MCKD, small corticomedullary cysts are com- and familial juvenile hyperuricemic nephropathy (FJHN). mon, but not always detected. Kidney size is normal or Methods. Haplotype analaysis for linkage to MCKD2 was slightly reduced. MCKD shows a renal histologic triad of performed in 25 MCKD families. In the kindreds showing (1) tubular basement disintegration, (2) tubular atrophy linkage to the MCKD2 locus on chromosome 16p12, muta- tional analysis of the UMOD gene was performed by exon with cyst development at the corticomedullary border, polymerase chain reaction (PCR) and direct sequencing. and (3) interstitial cell infiltration associated with fibrosis Results. In 19 families, haplotype analysis was compatible [2]. Neither imaging results, nor pathologic findings, are with linkage to the MCKD2 locus. All these kindreds were pathognomic for MCKD2. The condition shares clinical examined for mutations in the UMOD gene. In three different and morphologic similarities to recessive juvenile neph- families, three novel heterozygous mutations in the UMOD ronophthisis (NPH) [3]. In contrast to juvenile onset in gene were found and segregated with the phenotype in affected individuals. Mutations were found only in exon 4. NPH, end-stage renal failure in MCKD occurs in adult- Conclusion. We confirm the UMOD gene as the disease- hood. Moreover NPH is inherited in an autosomal-reces- causing gene for MCKD2. All three novel mutations were sive pattern, whereas MCKD is autosomal-dominant. found in the fourth exon of UMOD, in which all mutations Two loci for MCKD have been described: MCKD1 except one (this is located in the neighboring exon 5) published showed linkage to chromosome 1q21 in two Cypriot fam- so far are located. These data point to a specific role of exon 4 encoded sequence of UMOD in the generation of the MCKD2 ilies [4] and MCKD2 was localized on chromosome 16p12 renal phenotype. in an Italian family [1]. Two groups showed indepen- dently that loci for familial juvenile hyperuremic ne- phropathy (FJHN) and MCKD2 mapped to the same Key words: MCKD2, uromodulin, Tamm-Horsfall protein. chromosomal region on 16p12 [5, 6], assuming that FJHN and MCKD2 might be different facets of the same dis- Received for publication March 20, 2003 and in revised form May 28, 2003 ease caused by mutations in one and the same gene. Accepted for publication June 23, 2003 Later, an additional FJHN locus was mapped to a more 2003 by the International Society of Nephrology centromeric region [7] on chromosome 16, resulting in 1580 Wolf et al: Mutations in the UMOD gene in MCKD type 2 patients 1581 two different FJHN loci, which are overlapped by the 5 to 10 years, 4.1 Ϯ 1 mg/dL; female, 12 years, 4.5 Ϯ 0.9 MCKD2 locus [8]. Two years after publication of the mg/dL; 15 years, 4.5 Ϯ 0.9 mg/dL; Ն18 years, 4.0 Ϯ 0.7 chromosomal candidate region of MCKD2, Uromodulin mg/dL; male, 12 years, 4.4 Ϯ 1.1 mg/dL; 15 years, 5.5 Ϯ (UMOD) was published as excluded from representing 1.1 mg/dL; Ն18 years, 6.2 Ϯ 0.8) [18]. the disease-causing gene [9]. In contrast however, Hart The study was approved by the Ethics Committee of et al [10] later detected four different mutations in the the Albert-Ludwigs-University Freiburg and all partici- UMOD gene, indicating that this is the gene responsible pating family members provided informed consent. for FJHN and MCKD2. UMOD encodes the Tamm-Horsfall protein (THP), Haplotype analysis which is expressed primarily at the luminal side of renal Genomic DNA was isolated by standard methods di- epithelial cells of the thick ascending loop of Henle and rectly from blood samples using the QIAamp blood kit of early distal convoluted tubules. THP is the most abun- (Qiagen, Valencia, CA, USA) or from blood lymphocytes dant protein in the urine of humans [11]. Functional after Epstein-Barr virus (EBV) transformation. Haplo- roles of UMOD have been described in urinary tract type analysis was performed in 224 individuals (including infections, in binding to complement factors, in myeloma 84 affected individuals) and inferred in 18 additional kidney, and nephrolithiasis [12–15]. The UMOD protein individuals (nine additional affected individuals), using contains (1) a zona pellucida domain (ZP), which is 13 consecutive polymorphic microsatellite markers that necessary for polymerization into the supramolecular span the critical MCKD2 region in the following order: structure of a filament, (2) an elastase-sensitive fragment cen-D16S3116-D16S401-D16S3113-D16S420-D16S417- containing three calcium-binding epidermal growth fac- D16S412-D16-S3036-D16S3041-D16S3056-D16S501- tor (EGF)-like domains and a signal peptide, and (3) D16S499-D16S-3060-D16S764-tel. Fluorescently labeled a potential glycosyl-phosphatidylinositol (GPI)-anchor polymerase chain reaction (PCR) products were detected cleavage site. UMOD is a transmembrane-bound pro- by a Genetic Analyzer 3100 (Applied Biosystems, Foster tein, which can be secreted into the urine by cleavage City, CA, USA) and were analyzed by the GENOTYPER of the GPI-anchor [16]. software. We here report three novel mutations in UMOD and confirm UMOD as the disease-causing gene. So far, eight Mutational analysis of the UMOD gene mutations published are located in exon 4 and one muta- Mutational analysis was performed by exon PCR tion was found at the beginning of the neighboring exon of the Uromodulin gene. Primer sequences were deter- 5 of the UMOD gene that encodes three EGF-like do- mined using the UCSC sequence (November 2002 mains [10, 17]. freeze) encompassing the coding sequence of UMOD [19]. The following primers and conditions were em- ployed: exon 3, 5Ј-CAATCAAAGCACTCCTTCCAG- METHODS 3Ј and 5Ј-GACAGGTGCTACATTGCTTCC-3Ј; exon Patients 4 was divided into two different overlapping parts: exon We ascertained 25 MCKD families (224 individuals, 4a, 5Ј-CCTGGAGAATGAGGGAAGG-3Ј and 5Ј-CTG of which 84 were affected). Fourteen families were from GACGAGTACTGGCGC-3Ј; exon 4b, 5Ј-GGCAGCT Germany, three from the United States, two each from ACTTGTGCGTATG-3Ј and 5Ј-CTCTGCAGTGCCT the United Kingdom, Hungary, and Turkey, respec- TTCCAG-3Ј; exon 5, 5Ј-GTCTCCCCACAGTCCTC tively, one each from Belgium and China, respectively. ATC-3Ј and 5Ј-GGCAGTGACAGGTTTCTCAAC-3Ј; The age at diagnosis, the age at onset of end-stage renal exon 6, 5Ј-GGCCCCCAAGCTATAGACAC-3Ј and disease (ESRD), hyperuricemia, imaging data, and biopsy 5Ј-CCATGAATTGCTTTCTTTATTTG-3Ј; exon 7,5Ј- results were reviewed if available. Clinical criteria neces- TCATGCCCCTTTCTCTCATC-3Ј and 5Ј-GCTCATG sary for inclusion were (1) compatibility of pedigree GTTAAGGGGTTTG-3Ј; exon 8, 5Ј-TGCCTAGGA with autosomal-dominant inheritance, (2) chronic renal ATGCAAATCAG-3Ј and 5Ј-CCTTACCTGTCCTGG failure, (3) defective urine concentration (Ͻ800 mOsm/L ATGATG-3Ј; exon 9, 5Ј-TCAGCTCTGCACTGATGA after overnight dehydration) with polyuria (Ͼ3 L/day), CAG-3Ј and 5Ј-TGGCCAAATGTCTTTGGTTAC-3Ј; and (4) at least one pedigree member with chronic renal exon 10, 5Ј-AACCACATTCAGGCTCCTTC-3Ј and failure in whom renal biopsy showed tubulointerstitial 5Ј-AGGTGCCAGGCTCTGTTATC-3Ј; exon 11, 5Ј- fibrosis with infiltrates, tubular atrophy, and thickening GTCAGGATGCTTGCCAAATC-3Ј and 5Ј-CACTG of the tubular basement membrane. Optional clinical CAGAAAGGACCTGAAC-3Ј; and exon 12, 5Ј-GG criteria were normal or small-sized kidneys with occa- GTGTCCTCTTCTGATTGG-3Ј and 5Ј-CAGGTA sional small corticomedullary cysts. Hyperuricemia was CACCGTCACAAGTCC-3Ј using a “touch down” pro- defined as serum uric acid concentration Ͼ1 SD greater gram with a starting annealing temperature of 72ЊC (ex- than the normal values for age and gender (both genders ons 4a, 5, and 10), decreasing every step by 0.7ЊC for 24 1582 Wolf et al: Mutations in the UMOD gene in MCKD type 2 patients times and a next round of amplification with an annealing since there is age-related penetrance in MCKD. On this temperature of 55ЊC for 20 times.
Recommended publications
  • Label-Free Proteomic Methodology for the Analysis of Human Kidney Stone Matrix Composition Frank A
    Witzmann et al. Proteome Science (2016) 14:4 DOI 10.1186/s12953-016-0093-x METHODOLOGY Open Access Label-free proteomic methodology for the analysis of human kidney stone matrix composition Frank A. Witzmann1*, Andrew P. Evan2, Fredric L. Coe3, Elaine M. Worcester3, James E. Lingeman4 and James C. Williams Jr2 Abstract Background: Kidney stone matrix protein composition is an important yet poorly understood aspect of nephrolithiasis. We hypothesized that this proteome is considerably more complex than previous reports have indicated and that comprehensive proteomic profiling of the kidney stone matrix may demonstrate relevant constitutive differences between stones. We have analyzed the matrices of two unique human calcium oxalate stones (CaOx-Ia and CaOx-Id) using a simple but effective chaotropic reducing solution for extraction/solubilization combined with label-free quantitative mass spectrometry to generate a comprehensive profile of their proteomes, including physicochemical and bioinformatic analysis.` Results: We identified and quantified 1,059 unique protein database entries in the two human kidney stone samples, revealing a more complex proteome than previously reported. Protein composition reflects a common range of proteins related to immune response, inflammation, injury, and tissue repair, along with a more diverse set of proteins unique to each stone. Conclusion: The use of a simple chaotropic reducing solution and moderate sonication for extraction and solubilization of kidney stone powders combined with label-free quantitative mass spectrometry has yielded the most comprehensive list to date of the proteins that constitute the human kidney stone proteome. Keywords: Calcium oxalate, Kidney stone, Label-free quantitative liquid chromatography–tandem mass spectrometry, Matrix protein, Nephrolithiasis, Proteomics Background deposition is the primary event, at least in the formation The organic matrix within urinary stones has long been of CaOx stones over plaque.
    [Show full text]
  • Uromodulin Levels Associate with a Common UMOD Variant and Risk for Incident CKD
    CLINICAL EPIDEMIOLOGY www.jasn.org Uromodulin Levels Associate with a Common UMOD Variant and Risk for Incident CKD ʈ ʈ Anna Ko¨ttgen,* Shih-Jen Hwang,†‡ Martin G. Larson,§ Jennifer E. Van Eyk, Qin Fu, Emelia J. Benjamin,†¶ Abbas Dehghan,** Nicole L. Glazer,†† W.H. Linda Kao,* ʈʈ Tamara B. Harris,‡‡ Vilmundur Gudnason,§§ Michael G. Shlipak,¶¶ Qiong Yang,§ Josef Coresh,* Daniel Levy,†‡ and Caroline S. Fox†‡*** *Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland; †Framingham Heart Study, Framingham, Massachusetts; ‡Center for Population Studies, National Heart, Lung, and Blood Institute, and ‡‡Laboratory of Epidemiology, Demography, and Biometry, Intramural Research Program, National Institute on Aging, National Institutes of Health, Bethesda, Maryland; Departments of §Biostatistics and ʈ ¶Epidemiology, Boston University School of Public Health, Boston, Massachusetts; Department of Medicine, Johns Hopkins University, Baltimore, Maryland; **Department of Epidemiology, Erasmus Medical Centre, Rotterdam, Netherlands; ††Cardiovascular Health Research Unit and Department of Medicine, University of Washington, Seattle, ʈʈ Washington; §§Icelandic Heart Association Research Institute, Kopavogur, Iceland; University of Iceland, Reykjavik, Iceland; ¶¶General Internal Medicine Division, San Francisco VA Medical Center, University of California, San Francisco, California; and ***Division of Endocrinology, Metabolism, and Diabetes, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts ABSTRACT Common variants in the region of the UMOD gene, which encodes uromodulin (Tamm-Horsfall protein), associate with chronic kidney disease (CKD) and estimated GFR (eGFR). Whether uromodulin levels associate with UMOD variants or with the risk for developing CKD is unknown. We conducted an age- and gender- matched case-control study (n ϭ 200) of incident CKD (eGFR Ͻ60 ml/min per 1.73 m2) within the Framingham Heart Study (FHS).
    [Show full text]
  • Autosomal Dominant Tubulointerstitial Kidney Disease Genotype And
    www.nature.com/scientificreports OPEN Autosomal dominant tubulointerstitial kidney disease genotype and phenotype correlation in a Chinese cohort Kunjing Gong1,2,3,4, Min Xia1,2,3,4, Yaqin Wang1,2,3,4, Na Wang1,2,3,4, Ying Liu1,2,3,4, Victor Wei Zhang5,6, Hong Cheng 7 & Yuqing Chen1,2,3,4* Genes of UMOD, HNF1B, MUC1, REN and SEC61A1 were reported to be associated with autosomal dominant tubulointerstitial kidney disease (ADTKD). 48 probands and their family members (N = 27) were enrolled in this genetic screening study. A combination of methods was employed for comprehensive molecular analysis of both copy number variations (CNVs) and single nucleotide variants (SNVs). 35 probands were followed for years. The phenotype-genotype and genotype- outcome correlation were inferred from these datasets. In this cohort, 18 probands were diagnosed with ADTKD, according to Kidney Disease: Improving Global Outcomes (KDIGO) guideline. Moreover, 11 probands were diagnosed with ADTKD-UMOD, one with ADTKD-REN and one with ADTKD-HNF1B, based on molecularly confrmed pathogenic variants. The 11 UMOD variants were mainly located in codons 28 to 289 and half of the variants were found to change the cysteine amino acid. According to the follow-up data, suspected ADTKD individuals had a better prognosis compared to ADTKD individuals (p = 0.029). Individuals with a cysteine substitution in the UMOD gene appeared to have a better prognosis than individuals with other amino acid substitutions (p = 0.015). Autosomal dominant tubulointerstitial kidney disease (ADTKD) is considered to be one of the common causes of end stage renal disease (ESRD), especially in people whereby familial aggregation is observed1.
    [Show full text]
  • Uromodulin-Associated Kidney Disease
    Uromodulin-associated kidney disease Description Uromodulin-associated kidney disease is an inherited condition that affects the kidneys. The signs and symptoms of this condition vary, even among members of the same family. Many individuals with uromodulin-associated kidney disease develop high blood levels of a waste product called uric acid. Normally, the kidneys remove uric acid from the blood and transfer it to urine. In this condition, the kidneys are unable to remove uric acid from the blood effectively. A buildup of uric acid can cause gout, which is a form of arthritis resulting from uric acid crystals in the joints. The signs and symptoms of gout may appear as early as a person's teens in uromodulin-associated kidney disease. Uromodulin-associated kidney disease causes slowly progressive kidney disease, with the signs and symptoms usually beginning during the teenage years. The kidneys become less able to filter fluids and waste products from the body as this condition progresses, resulting in kidney failure. Individuals with uromodulin-associated kidney disease typically require either dialysis to remove wastes from the blood or a kidney transplant between the ages of 30 and 70. Occasionally, affected individuals are found to have small kidneys or kidney cysts (medullary cysts). Frequency The prevalence of uromodulin-associated kidney disease is unknown. It accounts for fewer than 1 percent of cases of kidney disease. Causes Mutations in the UMOD gene cause uromodulin-associated kidney disease. This gene provides instructions for making the uromodulin protein, which is produced by the kidneys and then excreted from the body in urine.
    [Show full text]
  • ASN Kidney Week 2019
    ONSITE GUIDE 20 19 Washington, DC Nov. 5–10 CORPORATE SUPPORTERS The ASN Corporate Support Program recognizes supporters year round for their generous contributions to the Society. Through this program, supporters help ASN lead the fight against kidney diseases. ASN gratefully acknowledges the following companies and organizations for their contributions in 2019. DIAMOND LEVEL PLATINUM LEVEL GOLD LEVEL Akebia Therapeutics OPKO Pharmaceuticals, LLC Amgen Retrophin, Inc. Janssen Pharmaceuticals, Inc. BRONZE LEVEL Amicus Therapeutics KDIGO Cara Therapeutics Rockwell Medical Daiichi Sankyo, Inc. Sanofi Genzyme GSK As of August 19, 2019 TABLE OF CONTENTS Kidney Week Mobile App 3 Schedule-at-a-Glance 4 Welcome 6 Accreditation, CE Credits, MOC Points 7 Certificates of Attendance for International Participants 8 Day-at-a-Glance: Tuesday, November 5 10 Day-at-a-Glance: Wednesday, November 6 12 Day-at-a-Glance: Thursday, November 7 14 Day-at-a-Glance: Friday, November 8 32 Day-at-a-Glance: Saturday, November 9 50 Scientific Exposition 64 Exhibitor Spotlights 66 Day-at-a-Glance: Sunday, November 10 69 Attention US Physicians To ensure full compliance with the Open Payments (Physician Payments Sunshine Act), a provision of the Patient Protection and Affordable Care Act (PL 111-148), ASN reserves the right to provide information to applicable manufacturers and applicable GPOs about US physicians (and their spouses) who participate in selected ASN activities. Section 6002 of the Affordable Care Act requires the establishment of a transparency program, now known as Open Payments. The program increases public awareness of financial relationships between drug and device manufacturers and certain healthcare providers.
    [Show full text]
  • Article Association Between Genotype and Phenotype in Uromodulin
    Article Association between Genotype and Phenotype in Uromodulin-Associated Kidney Disease Jonathan L. Moskowitz,* Sian E. Piret,† Karl Lhotta,‡§ Thomas M. Kitzler,| Adam P. Tashman,* Erin Velez,* Rajesh V. Thakker,† and Peter Kotanko* Summary Background and objectives Uromodulin-associated kidney disease (UAKD) is an autosomal dominant disease caused by uromodulin (UMOD) gene mutations. This study explored genotype-phenotype correlations by ex- *Renal Research Institute, New York, amining the relationship between the type of UMOD mutation and the age at onset of ESRD. New York; †Academic Endocrine Unit, Design, setting, participants & measurements Extensive bibliographic research was used to ascertain patient-level Radcliffe Department of Medicine, Oxford data of all patients with UAKD published up to October 2011. Data included sex; ages at onset of hyperuricemia, fi Centre for Diabetes, gout, and ESRD; and UMOD genotype. Kaplan-Meier analysis and Cox proportional hazards models tted with Endocrinology and shared gamma frailty terms to adjust for within-family correlations were used to model time to event. Metabolism, Churchill Hospital, University of Oxford, Oxford, Results Thirty-one peer-reviewed publications reporting on 202 patients from 74 families with 59 different United Kingdom; UMOD mutations were included. Median ages at onset of hyperuricemia, gout, and ESRD were 24, 40, and 56 ‡Department of years, respectively. Men developed gout and ESRD significantly earlier than did women (age at ESRD was 50 Nephrology and years for men and 60 for women; P=0.04, shared frailty model). Median ages at ESRD development were lowest Dialysis and §Vorarlberg Institute with Cys77Tyr (37.5 years) and highest with Gln316Pro (65.5 years) UMOD mutations.
    [Show full text]
  • A Cluster of Mutations in the UMOD Gene Causes Familial Juvenile Hyperuricemic Nephropathy with Abnormal Expression of Uromodulin
    J Am Soc Nephrol 14: 2883–2893, 2003 A Cluster of Mutations in the UMOD Gene Causes Familial Juvenile Hyperuricemic Nephropathy with Abnormal Expression of Uromodulin KARIN DAHAN,* OLIVIER DEVUYST,† MICHE` LE SMAERS,* DIDIER VERTOMMEN,† GUY LOUTE,§ JEAN-MICHEL POUX,ʈ BE´ ATRICE VIRON,¶ CHRISTIAN JACQUOT,# MARIE-FRANCE GAGNADOUX,** DOMINIQUE CHAUVEAU,†† MATHIAS BU¨ CHLER,‡‡ PIERRE COCHAT,§§ JEAN-PIERRE COSYNS,ʈʈ BE´ ATRICE MOUGENOT,¶¶ MARK H. RIDER,‡ CORINNE ANTIGNAC,## CHRISTINE VERELLEN-DUMOULIN*, and YVES PIRSON† *Université Catholique de Louvain, Center for Human Genetics, Brussels, Belgium; †Université Catholique de Louvain, Division of Nephrology, Brussels, Belgium; ‡Université Catholique de Louvain, International Institute of Cellular and Molecular Pathology, HORM Unit, Brussels, Belgium; §Hôpital Princesse Paola, Department of Nephrology, Aye, Belgium; ʈHôpital de Frejus, Department of Nephrology, Frejus, France; ¶Hôpital Bichat-Claude Bernard, Department of Nephrology, Paris, France; #Hôpital Georges Pompidou, Department of Nephrology, Paris, France; **Hôpital Necker, Department of Pediatric Nephrology, Paris, France; ††Hôpital Necker, Department of Nephrology and INSERM U507, Paris, France; ‡‡Centre Hospitalier Régional, Department of Nephrology, Tours, France; §§Hôpital Edouard Herriot, Department of Pediatric Nephrology, Lyon, France; ʈʈUniversité Catholique de Louvain, Department of Pathology, Brussels, Belgium; ¶¶Hôpital Tenon, Department of Pathology, Paris, France; and ##Université Paris V, Necker Hospital, INSERM U574, and Department of Genetics, Paris, France Abstract. Familial juvenile hyperuricemic nephropathy (FJHN consequences of UMOD mutations on uromodulin expression [MIM 162000]) is an autosomal-dominant disorder characterized were investigated in urine samples and renal biopsies from nine by abnormal tubular handling of urate and late development of patients in four families. There was a markedly increased expres- chronic interstitial nephritis leading to progressive renal failure.
    [Show full text]
  • The Uromodulin Gene Locus Shows Evidence of Pathogen Adaptation Through Human Evolution
    BRIEF COMMUNICATION www.jasn.org The Uromodulin Gene Locus Shows Evidence of Pathogen Adaptation through Human Evolution † ‡ Silvia Ghirotto,* Francesca Tassi,* Guido Barbujani,* Linda Pattini, Caroline Hayward, | Peter Vollenweider,§ Murielle Bochud,§ Luca Rampoldi, and Olivier Devuyst¶ *Department of Life Sciences and Biotechnology, University of Ferrara, Ferrara, Italy; †Department of Electronics, Information and Bioengineering, Politecnico di Milano, Milan, Italy; ‡Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, United Kingdom; §Department of Internal Medicine, Institute of Social and Preventive Medicine, Lausanne University Hospital Center, Lausanne, Switzerland; |Division of Genetics and Cell Biology, San Raffaele Scientific Institute, Milan, Italy; and ¶Institute of Physiology, University of Zurich, Zurich, Switzerland ABSTRACT Common variants in the UMOD gene encoding uromodulin, associated with risk and in mouse models of autosomal dom- of hypertension and CKD in the general population, increase UMOD expression inant tubulointerstitial kidney disease and urinary excretion of uromodulin, causing salt-sensitive hypertension and renal revealed intracellular aggregates of mu- lesions. To determine the effect of selective pressure on variant frequency, we in- tant uromodulin in the TAL cells, coupled vestigated the allelic frequency of the lead UMOD variant rs4293393 in 156 human with a systematic decrease of uromodulin populations, in eight ancient human genomes, and in primate genomes. The T allele excretion in the urine.9–11 of rs4293393, associated with CKD risk, has high frequency in most modern popu- In parallel, multiple genome-wide lations and was the one detected in primate genomes. In contrast, we identified association studies (GWAS) and se- only the derived, C allele in Denisovan and Neanderthal genomes.
    [Show full text]
  • The Cryo-EM Structure of the Human Uromodulin Filament Core Reveals A
    SHORT REPORT The cryo-EM structure of the human uromodulin filament core reveals a unique assembly mechanism Jessica J Stanisich1†, Dawid S Zyla1†, Pavel Afanasyev2, Jingwei Xu1, Anne Kipp3, Eric Olinger4, Olivier Devuyst3,5, Martin Pilhofer1, Daniel Boehringer2, Rudi Glockshuber1* 1Institute of Molecular Biology & Biophysics, ETH Zurich, Zurich, Switzerland; 2Cryo- EM Knowledge Hub (CEMK), ETH Zurich, Zurich, Switzerland; 3Institute of Physiology, University of Zurich, Zurich, Switzerland; 4Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Central Parkway, Newcastle upon Tyne, United Kingdom; 5Division of Nephrology, UCLouvain Medical School, Brussels, Belgium Abstract The glycoprotein uromodulin (UMOD) is the most abundant protein in human urine and forms filamentous homopolymers that encapsulate and aggregate uropathogens, promoting pathogen clearance by urine excretion. Despite its critical role in the innate immune response against urinary tract infections, the structural basis and mechanism of UMOD polymerization remained unknown. Here, we present the cryo-EM structure of the UMOD filament core at 3.5 A˚ resolution, comprised of the bipartite zona pellucida (ZP) module in a helical arrangement with a rise of ~65 A˚ and a twist of ~180˚. The immunoglobulin-like ZPN and ZPC subdomains of each monomer are separated by a long linker that interacts with the preceding ZPC and following ZPN *For correspondence: subdomains by b-sheet complementation. The unique filament architecture suggests
    [Show full text]
  • Tamm-Horsfall Protein Is a Critical Renal Defense Factor Protecting Against Calcium Oxalate Crystal Formation
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Kidney International, Vol. 66 (2004), pp. 1159–1166 Tamm-Horsfall protein is a critical renal defense factor protecting against calcium oxalate crystal formation LAN MO,HONG-YING HUANG,XIN-HUA ZHU,ELLEN SHAPIRO,DAVID L. HASTY, and XUE-RU WU Department of Urology, Kaplan Comprehensive Cancer Center, New York University School of Medicine, New York, New York; Department of Microbiology, Kaplan Comprehensive Cancer Center, New York University School of Medicine, New York, New York; Veterans Affairs Medical Center, New York, New York; Department of Anatomy and Neurobiology, University of Tennessee, Memphis, Tennessee; and Veterans Affairs Medical Center, Memphis, Tennessee Tamm-Horsfall protein is a critical renal defense factor protect- Renal stone disease or nephrolithiasis is an exceedingly ing against calcium oxalate crystal formation. common clinical condition in the industrialized world. Up Background. The tubular fluid of the mammalian kidney is of- to 15% of white males and 6% of all females will have ten supersaturated with mineral salts, but crystallization rarely occurs under normal conditions. The unique ability of the kid- at least one renal stone during their lifetime, and half ney to avoid harmful crystal formation has long been attributed of these individuals will experience recurrence [1, 2]. In to the inhibitory activity of the urinary macromolecules, al- the United States, the disease afflicts more than 1 million though few in vivo studies have been carried out to examine people annually and accounts for nearly 10 of every 1000 this hypothesis.
    [Show full text]
  • Overexpression of Uromodulin-Like1 Accelerates Follicle Depletion and Subsequent Ovarian Degeneration
    Citation: Cell Death and Disease (2012) 3, e433; doi:10.1038/cddis.2012.169 & 2012 Macmillan Publishers Limited All rights reserved 2041-4889/12 www.nature.com/cddis Overexpression of Uromodulin-like1 accelerates follicle depletion and subsequent ovarian degeneration W Wang*,1, Y Tang1,LNi1, E Kim1, T Jongwutiwes1, A Hourvitz2, R Zhang3, H Xiong3, H-C Liu1 and Z Rosenwaks1 Murine Uromodulin-like 1 (Umodl1) encodes Ca2 þ -dependent EGF-like membrane-bound proteins. This study presents its novel expression in the immune and female reproductive systems. Upon stimulation by CD3/CD28 antibodies, Umodl1 showed a prompt and robust response in the proliferating CD4 þ T cells, suggesting its implication in immune defense against pathogens. In ovary, Umodl1 is regulated by gonadotropins. Mice carrying extra copies of functional Umodl1 were generated by BAC transgenesis. Defects in the female reproductive system became evident from 4 months of age, manifested by reduced or diminished fertility. Histology revealed that the ovaries contained very few discernible follicles in the cortical region, and were devoid of distinguishable corpus lutea (CL). Among the multilayered preantral follicles, elevated apoptosis was observed in both the oocytes and surrounding granulosa cells (GCs). Furthermore, a high level of PPARc indicated an abnormal adipogenesis in the mutant ovaries, which resulted in the conversion of GCs into adipocytes. By 6 months of age, all mutant mice became anovulatory. Ovarian tissues including CL, follicles of various stages and associated stromal cells were degenerated. Altered expression of AMH, follicle-stimulating hormone and other ovary-specific marker genes such as Gdf-9, Rnf35, NOHLH and Gcx-1 further demonstrated that the molecular properties of the mutant ovaries have been severely disturbed.
    [Show full text]
  • Defective Intracellular Trafficking of Uromodulin Mutant Isoforms
    # 2006 The Authors Traffic 2006; 7: 1–13 Blackwell Munksgaard doi: 10.1111/j.1600-0854.2006.00481.x Defective Intracellular Trafficking of Uromodulin Mutant Isoforms Ilenia Bernascone1,†, Stefano Vavassori1,†, Key words: chronic renal diseases, ER retention, familial Alessio Di Pentima2, Sara Santambrogio1, juvenile hyperuricemic nephropathy, medullary cystic 3 4 kidney disease, protein trafficking, Tamm–Horsfall pro- Giuseppe Lamorte , Antonio Amoroso , tein, uromodulin Francesco Scolari5, Gian Marco Ghiggeri6, Giorgio Casari7, Roman Polishchuk2 and Received 30 April 2006, revised and accepted for publica- Luca Rampoldi1,* tion 26 July 2006 1Dulbecco Telethon Institute, DIBIT, San Raffaele Scientific Institute, Via Olgettina 58, 20132 Milan, Italy 2Department of Cell Biology and Oncology, Istituto di Uromodulin is the most abundant protein in human urine Ricerche Farmacologiche Mario Negri, Via Nazionale, under physiological conditions, being excreted at a rate of 66030 Santa Maria Imbaro, Chieti, Italy 50–100 mg per day (1). It was initially characterized by 3Biotechnology and Biosciences Department, Tamm and Horsfall in 1950 (2), and it is also referred to University of Milan Bicocca, Piazza della Scienza 2, as Tamm–Horsfall protein. Uromodulin is found in urine 20126 Milan, Italy 6 4Department of Genetics, Biology and Biochemistry, as a high-molecular-weight polymer (Mr 1–10 Â 10 ) that University of Turin, Via Santena 19, 10126 Turin, Italy can be dissociated into monomers of about 95 kDa (3). 5Division of Nephrology, Spedali Civili and University of It is a glycoprotein with seven out of eight potential N- Brescia, Piazzale Spedali Civili 1, 25125 Brescia, Italy glycosylation sites being glycosylated; N-glycans account 6 Laboratory on Pathophysiology of Uremia, G.
    [Show full text]